A double-blind, placebo-controlled, intervention trial comparing the triglyceride-lowering effect of omega-3 polyunsaturated fatty acids, as either ethyl ester or triglycerides in patients with moderately elevated triglyceride levels in the blood in non fasting state.

Registry ID

EUCTR2012-003029-11

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

Steen Stender

Start date

2012-09-10

Completion date

2013-11-22

Last update

2026-08-16

Conditions

• Hypertriglyceridemia

Summary

A comparison of the triglyceride lowering effect, in th non-fasting state of the prescription drug Lovaza/Omacor given in the approved dose of 4 g/day (1,860 mgEPA + 1,500 mg DHA in the ethyl ester form) to that of a non-presription

Locations

• , , Denmark

Related clinical trials

• Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
• Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
• A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
• Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
• A Study to Assess the Safety, Tolerability and Efficacy of ION775
• A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque

View on source registry